JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 14, 2007; DOI: 10.1124/jpet.107.122929


0022-3565/07/3223-1076-1083$20.00
JPET 322:1076-1083, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.122929v1
322/3/1076    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ouyang, W.
Right arrow Articles by Hemmings, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ouyang, W.
Right arrow Articles by Hemmings, H. C., Jr.

NEUROPHARMACOLOGY

Isoflurane Inhibits NaChBac, a Prokaryotic Voltage-Gated Sodium Channel

Wei Ouyang, Ting-Yu Jih, Tao-Tao Zhang, Ana M. Correa, and Hugh C. Hemmings, Jr.

Departments of Anesthesiology (W.O., T.-Y.J., T.-T.Z., H.C.H.) and Pharmacology (H.C.H.), Weill Cornell Medical College, New York, New York; and Department of Pediatrics, Institute for Molecular Pediatric Sciences, University of Chicago, Chicago, Illinois (A.M.C.)

Volatile anesthetics inhibit mammalian voltage-gated Na+ channels, an action that contributes to their presynaptic inhibition of neurotransmitter release. We measured the effects of isoflurane, a prototypical halogenated ether volatile anesthetic, on the prokaryotic voltage-gated Na+ channel from Bacillus halodurans (NaChBac). Using whole-cell patch-clamp recording, human embryonic kidney 293 cells transfected with NaChBac displayed large inward currents (INa) that activated at potentials of –60 mV or higher with a peak voltage of activation of 0 mV (from a holding potential of –80 mV) or –10 mV (from a holding potential of –100 mV). Isoflurane inhibited INa in a concentration-dependent manner over a clinically relevant concentration range; inhibition was significantly more potent from a holding potential of –80 mV (IC50 = 0.35 mM) than from –100 mV (IC50 = 0.48 mM). Isoflurane positively shifted the voltage dependence of peak activation, and it negatively shifted the voltage dependence of end steady-state activation. The voltage dependence of inactivation was negatively shifted with no change in slope factor. Enhanced inactivation of INa was 8-fold more sensitive to isoflurane than reduction of channel opening. In addition to tonic block of closed and/or open channels, isoflurane enhanced use-dependent block by delaying recovery from inactivation. These results indicate that a prokaryotic voltage-gated Na+ channel, like mammalian voltage-gated Na+ channels, is inhibited by clinical concentrations of isoflurane involving multiple state-dependent mechanisms. NaChBac should provide a useful model for structure-function studies of volatile anesthetic actions on voltage-gated ion channels.


Received March 16, 2007; accepted June 13, 2007.

Address correspondence to: Dr. Hugh C. Hemmings, Weill Cornell Medical College, Box 50, LC-203, 525 E. 68th St., New York, NY 10065-4896. E-mail: hchemmi{at}med.cornell.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.